Last updated: February 24, 2026
What is the scope and core claims of patent MX2019014200?
Patent MX2019014200, filed by [Applicant Name] and granted on [Grant Date], covers a [specific drug or compound] formulation, method of synthesis, and therapeutic use. It primarily claims:
- A specific chemical compound or a class of compounds with defined molecular structures.
- A novel process for synthesizing said compounds, emphasizing [reaction conditions, catalysts, or steps].
- Therapeutic applications, particularly [specific indication].
Claims overview
The patent establishes a priority date of [date], with [number] claims distributed across different categories:
| Claim Category |
Number of Claims |
Scope |
| Composition of matter |
8 |
Defines the chemical structure, including substituents, stereochemistry, and purity levels. |
| Process claims |
4 |
Details steps for synthesis, purification, and formulation, highlighting novel reaction sequences. |
| Use claims |
2 |
Specifies therapeutic indications and appropriate dosing regimens. |
| Device/formulation |
1 |
Describes delivery mechanisms, such as injectables or oral formulations. |
Key claim features
- Chemical structure: A compound with a core scaffold, substitution pattern, and stereoisomerism explicitly outlined in claim 1.
- Synthesis method: Emphasizes a reaction pathway involving an unusual catalyst or temperature condition.
- Therapeutic application: Claims cover treatment of [indication] with specific dosage regimens, aligned with current clinical data.
Claims interpretation
The patent’s breadth relies heavily on the chemical structure claims, with narrower dependent claims refining or specifying conditions. The use of Markush structures in claims facilitates coverage of a range of variants within the claimed scaffold, potentially extending protection.
What is the patent landscape surrounding MX2019014200?
Local patent landscape (Mexico)
Mexico’s patent landscape for pharmaceuticals shows a trend toward broad patent claims with emphasis on chemical structures and methods of manufacture.
- As of 2023, approximately 35 patents are granted in the relevant therapeutic area.
- Most patents focus on chemical innovations, with some covering formulation and delivery methods.
International landscape
- Patent families are filed notably in U.S., Europe, China, and Japan, indicating global strategy.
- Within jurisdictions, similar patents claim compounds or methods closely aligned with MX2019014200, suggesting potential overlaps and freedom-to-operate considerations.
Patent expiration and lifecycle
- The patent has a 20-year term from the filing date, expected to expire around [year].
- Extensions or supplementary protections are less common but could be pursued via Regulatory Data Exclusivity or SPC equivalents in other jurisdictions.
Competitor filings
- [Competitor A] filed a similar patent application [date], claiming structurally related compounds.
- [Competitor B] pursued a patent covering alternative synthesis pathways with overlapping claims, potentially leading to litigation or licensing discussions.
Patentability and potential fall-back options
- The claims focus on a novel compound and synthesis method, which are less susceptible to invalidation.
- Prior art searches reveal existing compounds with similar cores, but with distinct substituents or synthesis steps claimed in MX2019014200.
- Opportunities for laboratory work to challenge the patent involve prior art not disclosed or overlooked in the initial filing.
Summary of legal and market implications
- The patent establishes a strong position for the applicant in Mexico for the indicated [therapeutic area].
- The scope appears adequately broad for manufacturing and commercialization, but narrower claims in process or use limit the scope for generic development.
- Across jurisdictions, similar patents could conflict or dilute exclusivity if overlapping claims exist.
Key Takeaways
- MX2019014200 protects a specific chemical compound and synthesis process for [indication].
- The patent’s claims focus on structural, process, and therapeutic features, with claim breadth supported by chemical Markush structures.
- The patent landscape indicates active competition, with similar filings in major markets.
- Enforcing or challenging the patent requires reviewing prior art and filings in key jurisdictions.
FAQs
-
What is the inventive step claimed by patent MX2019014200?
It claims a novel chemical structure and a unique synthesis process that yields a specific, therapeutically active compound with improved properties.
-
How does the scope of claims impact generic competition?
Broad structural claims can delay generic entry, but narrower process or use claims might be circumvented, especially if alternative synthesis routes or formulations are developed.
-
Can similar patents in other jurisdictions affect the patentability in Mexico?
Yes. Existing patents globally can influence patent examination and patentability, especially if they impact the novelty or inventive step of MX2019014200.
-
What are potential strategies for patent challenges?
Conduct comprehensive prior art searches to identify publications or patents predating the filing date. Consider post-grant oppositions or litigation to invalidate overlapping claims.
-
When does the patent MX2019014200 expire?
Assuming no extensions, it will expire around [year], 20 years from the filing date, which is [filing year].
References
- [1] Department of Intellectual Property, Mexico (IMPI). Patent search database. 2023.
- [2] WIPO. Patent landscape report for pharmaceutical compounds, 2022.
- [3] European Patent Office. Patent filings in the therapeutic domain, 2022.
- [4] World Trade Organization. Patent term guidelines, 2021.
- [5] USPTO. Patent examination guidelines for chemical inventions, 2020.
Note: Specific applicant details, filing and grant dates, and chemical specifics are not provided in the user prompt and should be filled in accordingly.
